Literature DB >> 15103490

Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas.

Elke Roeb1, Marlies Arndt, Bettina Jansen, Volker Schumpelick, Siegfried Matern.   

Abstract

BACKGROUND AND AIMS: MMP-7, a member of the matrix metalloproteinase family, is believed to play a significant role in the growth and proliferation of colon cancer cells. The aim of this study was to evaluate MMP-7 gene expression in comparison with MMP-1, MMP-3, and MMP-13 in patients with resectable rectal and colon cancer by a semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR).
MATERIALS AND METHODS: Biopsy samples of tumor ( n=30) and distant normal mucosa ( n=30) from 30 patients were obtained intraoperation. Messenger (m)RNA was extracted from all of the tissue samples and reverse transcribed to double-stranded cDNA. Semi-quantitative RT-PCR was performed to study the MMP gene expression in both the tumor and normal mucosal specimens. MMP mRNA values were expressed relative to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) for each sample.
RESULTS: In all 30 cases an increase in MMP-7 mRNA expression was detected in the cancerous tissue ( p=0.00004). In 21 out of 30 cases an increase in MMP-13 mRNA ( p=0.023) and in 22 out of 30 cases an increase in MMP-3 mRNA ( p=0.075) was detected in the cancerous tissue. In contrast, there was no significant change in the MMP-1 expression of normal and cancerous mucosal specimens in either colon or rectal carcinomas. There were no significant differences between rectum and colon carcinomas.
CONCLUSION: Taking into account our earlier studies, we conclude that most cases of colorectal carcinogenesis are characterized by enhanced expression of MMP-7, -13, -3 and the gelatinases, whereas MMP-1-expression is very inconsistent and not overexpressed in many cases. MMP-7 inhibition as well as inhibition of MMP-13 and MMP-3 may be a useful preventive or therapeutic adjunct in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15103490     DOI: 10.1007/s00384-004-0592-6

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  34 in total

1.  An MMP-9 mutant without gelatinolytic activity as a novel TIMP-1-antagonist.

Authors:  E Roeb; I Behrmann; J Grötzinger; B Breuer; S Matern
Journal:  FASEB J       Date:  2000-09       Impact factor: 5.191

Review 2.  Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis.

Authors:  S Curran; G I Murray
Journal:  Eur J Cancer       Date:  2000-08       Impact factor: 9.162

Review 3.  Collagenases (second of three parts).

Authors:  E D Harris; S M Krane
Journal:  N Engl J Med       Date:  1974-09-19       Impact factor: 91.245

4.  Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features.

Authors:  L Nakopoulou; I Giannopoulou; H Gakiopoulou; H Liapis; A Tzonou; P S Davaris
Journal:  Hum Pathol       Date:  1999-04       Impact factor: 3.466

5.  Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis.

Authors:  Philippe E Van den Steen; Paul Proost; Bernard Grillet; David D Brand; Andrew H Kang; Jo Van Damme; Ghislain Opdenakker
Journal:  FASEB J       Date:  2002-03       Impact factor: 5.191

6.  Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9.

Authors:  Z S Zeng; Y Huang; A M Cohen; J G Guillem
Journal:  J Clin Oncol       Date:  1996-12       Impact factor: 44.544

7.  Human progelatinase A can be activated by matrilysin.

Authors:  T Crabbe; B Smith; J O'Connell; A Docherty
Journal:  FEBS Lett       Date:  1994-05-23       Impact factor: 4.124

8.  Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.

Authors:  K J Newell; J P Witty; W H Rodgers; L M Matrisian
Journal:  Mol Carcinog       Date:  1994-08       Impact factor: 4.784

9.  Expression of matrilysin mRNA in colorectal adenomas and its induction by truncated fibronectin.

Authors:  H Yamamoto; F Itoh; Y Hinoda; A Senota; M Yoshimoto; H Nakamura; K Imai; A Yachi
Journal:  Biochem Biophys Res Commun       Date:  1994-06-15       Impact factor: 3.575

10.  Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas.

Authors:  T Masaki; H Matsuoka; M Sugiyama; N Abe; A Goto; A Sakamoto; Y Atomi
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640

View more
  23 in total

1.  Common polymorphism in the MMP-13 gene may contribute to the risk of human cancers: a meta-analysis.

Authors:  Ping Gao; Jun-Lan Yang; Hong Zhao; Jun-Hao You; Yi Hu
Journal:  Tumour Biol       Date:  2014-07-15

2.  Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.

Authors:  O Schwandner; A Schlamp; R Broll; H P Bruch
Journal:  Int J Colorectal Dis       Date:  2006-08-02       Impact factor: 2.571

3.  Protein kinase D1 mediates synergistic MMP-3 expression induced by TNF-α and bradykinin in human colonic myofibroblasts.

Authors:  James Yoo; Citlali Ekaterina Rodriguez Perez; Wenxian Nie; James Sinnett-Smith; Enrique Rozengurt
Journal:  Biochem Biophys Res Commun       Date:  2011-08-16       Impact factor: 3.575

4.  Matrix metalloproteinase-13 (MMP-13) directly and indirectly promotes tumor angiogenesis.

Authors:  Yasusei Kudo; Shinji Iizuka; Maki Yoshida; Takaaki Tsunematsu; Tomoyuki Kondo; Ajiravudh Subarnbhesaj; Elsayed M Deraz; Samadarani B S M Siriwardena; Hidetoshi Tahara; Naozumi Ishimaru; Ikuko Ogawa; Takashi Takata
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

5.  PDEF is a negative regulator of colon cancer cell growth and migration.

Authors:  Omar Moussa; David P Turner; Ron J Feldman; Victor I Sementchenko; Brent D McCarragher; Mohamed M Desouki; Mostafa Fraig; Dennis K Watson
Journal:  J Cell Biochem       Date:  2009-12-15       Impact factor: 4.429

6.  SPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity.

Authors:  Taeko K Noah; Yuan-Hung Lo; Allison Price; Gang Chen; Eileen King; Mary-Kay Washington; Bruce J Aronow; Noah F Shroyer
Journal:  Gastroenterology       Date:  2013-02-01       Impact factor: 22.682

7.  The association of matrix metalloproteinase-1 genetic polymorphism (-1607 1G>2G) with colorectal cancer: a meta-analysis.

Authors:  Shu-Rong Ji; Jian-Jun Sun; Xin-Ping Li; Yi Zhang; Wen-Fang Liu
Journal:  Tumour Biol       Date:  2013-07-20

Review 8.  Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer--a review focusing on open questions.

Authors:  Lutz Moser; Jörg-Peter Ritz; Wolfgang Hinkelbein; Stefan Höcht
Journal:  Int J Colorectal Dis       Date:  2007-12-07       Impact factor: 2.571

9.  ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression.

Authors:  Kensuke Kumamoto; Kaori Fujita; Reiko Kurotani; Motonobu Saito; Motoko Unoki; Nobutoshi Hagiwara; Hideaki Shiga; Elise D Bowman; Nozomu Yanaihara; Shu Okamura; Makoto Nagashima; Kotaro Miyamoto; Seiichi Takenoshita; Jun Yokota; Curtis C Harris
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

10.  Matrix metalloproteinase-13 is regulated by toll-like receptor-9 in colorectal cancer cells and mediates cellular migration.

Authors:  Timo Rath; Julia Stöckle; Martin Roderfeld; Annette Tschuschner; Jürgen Graf; Elke Roeb
Journal:  Oncol Lett       Date:  2011-03-21       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.